-
THE IMPACT OF BREXIT ON PHARMACEUTICAL REGULATION AND APPROVAL IN THE UK
Aug 11, 2026, 17:16 PM -
A MEETING WITHOUT A RECORD: THE PROCEDURAL EMPTINESS OF THE PICO CLARIFICATION MEETING IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
THE ASSOCIATION BETWEEN EVENT-FREE SURVIVAL (EFS) AND OVERALL SURVIVAL (OS) IN HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) IN THE NETHERLANDS: AN OBSERVATIONAL STUDY OF ELECTRONIC HEALTH RECORDS
Aug 11, 2026, 17:16 PM -
A REAL-WORLD PHARMACOECONOMIC EVALUATION OF CAMRELIZUMAB PLUS CHEMOTHERAPY FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA UNDER THE NATIONAL REIMBURSEMENT DRUG LIST NEGOTIATION POLICY IN CHINA
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF MODEL-INFORMED PRECISION DOSING VERSUS GUIDELINE DOSING FOR POLYMYXIN B: A SIMULATION-BASED ECONOMIC EVALUATION
Aug 11, 2026, 17:16 PM -
WORK-RELATED MUSCULOSKELETAL DISORDERS AND QUALITY OF WORK LIFE IN BAKERY WORKERS
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION (HCRU) AND COSTS OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN SWEDEN: A NATIONAL REGISTRY STUDY COMPARING PATIENTS WITH MATCHED POPULATION CONTROLS
Aug 11, 2026, 17:16 PM -
ACCURACY OF CLOUD-BASED LARGE LANGUAGE MODELS TO SCREEN ABSTRACTS FOR TARGETED LITERATURE REVIEWS VARIES BY TOPIC
Aug 11, 2026, 17:16 PM -
EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSIS OF IMMUNOTHERAPY OR TARGETED THERAPY FOR CHINESE PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A NETWORK META-ANALYSIS AND SEQUENTIAL MODEL
Aug 11, 2026, 17:16 PM -
TRIMETHYLAMINE N-OXIDE AS A BIOMARKER OF ATHEROSCLEROSIS: AN EXPLORATORY STUDY IN A SOUTH INDIAN COHORT
Aug 11, 2026, 17:16 PM -
REIMBURSEMENT OF NEW ORPHAN MEDICINES IN FINLAND: A SURVIVAL ANALYSIS OF ACCESS DELAYS
Aug 11, 2026, 17:16 PM -
THE HYPOTHETICAL SCENARIO-BASED COMPARATIVE ASSESSMENT (SCAN) MODEL: EVALUATING HEALTHCARE RESOURCE UTILISATION ACROSS TREATMENT STRATEGIES FOR REFRACTORY OR UNEXPLAINED CHRONIC COUGH
Aug 11, 2026, 17:16 PM -
BARRIERS AND POTENTIAL SOLUTIONS TO THE USE OF REAL-WORLD DATA AND EVIDENCE IN DECISION-MAKING FOR ADVANCED THERAPY MEDICINAL PRODUCTS: A MULTI-STAKEHOLDER QUALITATIVE STUDY
Aug 11, 2026, 17:16 PM -
CARDIOMETABOLIC DISEASE POLICY MODEL: SUPPORTING LONG-TERM HEALTH, ECONOMIC, AND INEQUALITY EVALUATION
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE AFTER BARIATRIC SURGERY IN SINGAPORE
Aug 11, 2026, 17:16 PM -
A FRAMEWORK APPROACH TO ASSESS THE EVIDENCE GENERATION NEEDS FOR TWO NOVEL TREATMENTS IN SICKLE CELL DISEASE PREPARING FOR UK HEALTH TECHNOLOGY ASSESSMENT: A CASE STUDY
Aug 11, 2026, 17:16 PM -
ADDRESSING THE LOW-COST COMPARATOR PROBLEM: SOLUTIONS TO PREVENT SYSTEMATIC BARRIERS TO HEALTHCARE INNOVATION IN COST-EFFECTIVENESS-BASED SYSTEMS
Aug 11, 2026, 17:16 PM -
IDENTIFYING PATTERNS IN LUNG CANCER HEALTH TECHNOLOGY ASSESSMENT OUTCOMES ACROSS ENGLAND AND GERMANY USING AN AI-ENABLED MARKET ACCESS INTELLIGENCE PLATFORM
Aug 11, 2026, 17:16 PM -
OUTCOMES IN INFLUENZA PHASE III/IV CLINICAL TRIALS: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
CLINICIAN GLOBAL IMPRESSION OF SEVERITY AND CHANGE SCALES FOR CUTANEOUS LUPUS ERYTHEMATOSUS: COGNITIVE DEBRIEFING EVIDENCE SUPPORTING CLINICAL UTILITY
Aug 11, 2026, 17:16 PM
